RB1 and neoplasm: Since tumor material was not available, peripheral assessment of methylation of the RB1 promoter in leukocytes would not have been informative because the dynamics of DNA methylation in primary tumor tissues are clearly different from normal cells, and not confined to specific CpG sites [13].